Adding Indian cGMP HPAPI capabilities builds on Arch’s strategy of differentiating through technology and establishes it in an emerging and profitable sector.
Drug industry demand for chemical intermediates and development projects has rebounded significantly in the last 12 months according to UK group Endeavour Specialty Chemicals.
Prosonix expects high demand for innovative particle processing technologies in the $24bn (€17bn) a-year respiratory pharmaceuticals market over the next few years.
IDT Biologika.says demand for vaccines in emerging markets is big chance for Big Pharma and hence a growing niche for contractors with the technical capabilities to carry out such work.
Guy Villax, board member of the EFCG, talks falsified APIs, EU efforts to tackle the issue, and the presence of gangsters in the pharma industry in an in-PharmaTechnologist video interview.
Greater recognition of toxicity risks of HPAPIs and continued growth of oncology sector are driving drug industry demand for safe manufacturing capacity says US fine molecules firm SAFC Pharma.
RXi Pharmaceuticals has applied its sd-rxRNA to dermal cells, establishing the efficacy of the technology as it seeks to move it on to the next stage of development, a company VP told in-PharmaTechnologist.
The aging population is driving manufacturers to develop packaging that is easier to open, while still remaining child-resistant, but this can increase costs and affect sustainability, according to a director.
Companies are failing to protect their products with tamper evidence but the EU falsified medicine directive, plus the ease of implementation, will drive adoption, according to a director at Schreiner ProSecure.
Using intelligent compliance packaging in clinical trials can result in “huge cost savings” and this will ensure demand even during a period of cost-cutting, according to a sales manager at Stora Enso.
Schott AG has launched its InJentle syringe to improve the stability of highly sensitive drugs, which is a “major topic” for the company’s clients, according to a company director.
Welcome to this seasonal holiday video from Decision News Media.As we prepare to celebrate our tenth anniversary next year and first year as part of William Reed Business Media, we present 10 fun number facts about our company. And, later this week, the...
Don’t miss this video interview with Robert Marr, chief operating officer of William Reed Business Media which recently acquired Decision News Media publisher of CosmeticsDesign-Europe.com and CosmeticsDesign.com.
US strategic consultants CourtSquareGroup say that while optimisation of operations is key for the drug industry, companies risk losing the business knowledge required to undertake such action in the scramble to cut costs in the global downturn.
Companies are maintaining their spending on quality control measures despite the challenging operating environment, according to Matthew Kopecky, product manager at Sparta Systems.
PTI Packaging Systems chose this year's Interphex show to introduce its new unit dose, or "stick pack," production machine to the North American packaging sector.
The use of intelligent sorbents to improve product stability can save companies six to 12 months of development and boost revenues, according to Adrian Possumato, global director at Multisorb.
PTI’s non-destructive micro leak tester can cut costs for companies using dye ingress, according to general manager Heinz Wolf, who demonstrated the technology to in-PharmaTechnologist at Interphex.
Pall’s Stax single-use depth filter attracted interest from a “number of biotechnology companies” at Interphex, according to director of marketing Ian Sellick who explained how the system can save space, time and money.
Since coming into effect late last year, US Code of Federal Regulations-21 parts 210 and 211 testing rules have been the subject of much confusion in the pharmaceutical industry, according to West Pharmaceutical Services.
Flexibility is going to be a key driver for the pharmaceutical market in the next few years, according to Millipore's VP of downstream processing Paul Chapman.
The global economic downturn, impending blockbuster patent expiries and the wave of consolidation sweeping the pharmaceutical industry will drive demand for Patheon’s restructuring service according to CEO Wesley Wheeler.
SGD launched its new lyophilisation vials at Pharmapack 2009, which Vincent Langlade, Marketing Director Pharmaceuticals, explained were well suited to capture the growing market.
As the sophistication of counterfeit drug packaging continues to improve it is becoming harder and harder to tell real products from fake. in-PharmaTechnologist spoke with Alpvision's Roland Meylan about the company's approach to brand authentication.
We spoke with Martijn Eijkenboom, president of NAF & VSM, to discuss his companies’ entry into the market for pre-washed vials, ampoules and test tubes.
